Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Real-Life Experience of Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Syndrome Patients

Blood (2024) 144 (Supplement 1): 6737.

https://doi.org/10.1182/blood-2024-202478

Published: 2024

Journal Articles

In vivo HSC prime editing rescues sickle cell disease in a mouse model

Chang Li, Aphrodite Georgakopoulou, Gregory A. Newby, Peter J. Chen, Kelcee A. Everette, Kiriaki Paschoudi, Efthymia Vlachaki, Sucheol Gil, Anna K. Anderson, Theodore Koob, Lishan Huang, Hongjie Wang, Hans-Peter Kiem, David R. Liu, Evangelia Yannaki, André Lieber

Blood (2023) 141 (17): 2085–2099.

https://doi.org/10.1182/blood.2022018252

Published: 2023

Includes: Supplemental data

Journal Articles

Real-World Data on the Use of Luspatercept in Greek Patients with Transfusion Dependent Thalassemia

Blood (2022) 140 (Supplement 1): 8205–8207.

https://doi.org/10.1182/blood-2022-167675

Published: 2022

Journal Articles

Prospective Study of Complement Activation with Functional and Genetic Assays in Sickle Cell Disease

Christos Varelas, Efthymia Vlachaki, Filippos Klonizakis, Despoina Pantelidou, Fani Minti, Michael D. Diamantidis, Nikolaos Sampanis, Ioanna Giatagantzidou, Despoina Papadopoulou, Evdoxia Koravou, Ioanna Christodoulou, Evaggelia Zarkada, Tasoula Touloumenidou, Apostolia Papalexandri, Ioanna Sakellari, George Vassilopoulos, Robert Brodsky, Eleni Gavriilaki

Blood (2022) 140 (Supplement 1): 2504–2505.

https://doi.org/10.1182/blood-2022-164554

Published: 2022

Journal Articles

Sickle-Cell Disease in Greece: Patient Reported Outcomes Related to Clinical Complications, Treatment Choices and Attitudes, Beliefs and Trends Affecting Potential Participation in Clinical Trials - a Greek National Multicentric Study

Sophia Delicou, Michael D. Diamantidis, MD PhD MSc, Konstantinos Manganas, Eftychios Eftychiadis, MD, Despoina Pantelidou, MD PhD, Alexandra Kourakli, MD PhD, Efthymia Vlachaki, MBBS, Loukia Evliati, Ioannis Lafiatis, Evangelos Klironomos, MD, Dimitra Kyriakopoulou, MD, Aikaterini Xydaki, Vassiliki Bartzi, Despoina Papadopoulou, Vasileios Lazaris, Chrysoula Apostolou, Antonis Kattamis, Argiris Symeonidis, MD PhD

Blood (2019) 134 (Supplement_1): 4838.

https://doi.org/10.1182/blood-2019-127966

Published: 2019

Journal Articles

Plasmic and Plasic Αre Εxcellent Predictors of Severe ADAMTS13 Deficiency in Thrombotic Microangiopathy Patients without Secondary Causes

Blood (2019) 134 (Supplement_1): 4913.

https://doi.org/10.1182/blood-2019-125343

Published: 2019

Journal Articles

Hepatitis C Virus Infection, but Not Hepatic Iron Overload Is the Dominant Risk Factor for the Manifestation of Hepatocellular Carcinoma Among Greek Thalassemic Patients

Blood (2018) 132 (Supplement 1): 2347.

https://doi.org/10.1182/blood-2018-99-119731

Published: 2018

Journal Articles

Neurological Manifestations Due to Extramedullary Hematopoiesis in Greek Patients with Thalassemia Intermedia: Not Such a Rare Clinical Finding

Michael D. Diamantidis, MD PhD MSc, Alexandra Kourakli, MD PhD, Efthymia Vlachaki, MBBS, Despoina Pantelidou, MD PhD, Evgenia Verigou, Evangelos Alexiou, Fotios Girtovitis, PhD MD, Paraskevi Fotiou, Elisavet Grouzi, Argiris Symeonidis, MD PhD

Blood (2018) 132 (Supplement 1): 2349.

https://doi.org/10.1182/blood-2018-99-119376

Published: 2018

Journal Articles

The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions

Blood (2018) 132 (Supplement 1): 163.

https://doi.org/10.1182/blood-2018-163

Published: 2018

Journal Articles

Demographic, Clinical and Laboratory Features, Management and Outcome of Immune Thrombocytopenia (ITP) in Greece: The National ITP Registry of the Hellenic Society of Hematology

Blood (2017) 130 (Supplement 1): 4859.

https://doi.org/10.1182/blood.V130.Suppl_1.4859.4859

Published: 2017

Journal Articles

Patients with Myelodysplastic Syndromes, Other Than Del(5)q Syndrome, Exhibiting Del(5)q Alone or Associated with One Additional Chromosomal Abnormality Have Comparable Probability and Duration of Response to Lenalidomide, with Patients Classified As Del(5)q Syndrome

Argiris Symeonidis, MD PhD, Alexandra Kourakli, MD, Ioannis Kotsianidis, MD PhD, Panagiotis Zikos, Eleftheria Hatzimichael, Theodoros Vassilakopoulos, MDPhD, Aikaterini Palla, Vassiliki Pappa, MD, Evgenia Verigou, Zafeirios Kartasis, MD, Eirini Katodritou, Maria Pagoni, Theodora Assimakopoulou, Charalampos Pontikoglou, MD PhD, Maria Dimou, George Xanthopoulidis, Maria K. Angelopoulou, MD, Maria Kotsopoulou, Dimitra Liapi, Despina Mparmparousi, Evridiki Michali, Anna Kioumi, Nora-Athina Viniou, Achilles Anagnostopoulos, Vassiliki Labropoulou, Maria Dalekou, Michael Voulgarelis, MD PhD, Efthymia Vlachaki, Anna Christoforidou, Ioannis Adamopoulos, MD, Akrivi Kostourou, Petros Laos, Evangelos Terpos, MD PhD, Eleni Kapsali, George Vassilopoulos, MD PhD, Helen A. Papadaki, MD PhD, Panayiotis Panayiotidis, MD PhD, Athanasios Galanopoulos, MD PhD

Blood (2017) 130 (Supplement 1): 1696.

https://doi.org/10.1182/blood.V130.Suppl_1.1696.1696

Published: 2017

Journal Articles

Greek Registry of Myelofibrosis: Baseline Characteristics and Therapeutic Strategy

Blood (2014) 124 (21): 5557.

https://doi.org/10.1182/blood.V124.21.5557.5557

Published: 2014

NARROW

Real-Life Experience of Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Syndrome Patients

In vivo HSC prime editing rescues sickle cell disease in a mouse model

Real-World Data on the Use of Luspatercept in Greek Patients with Transfusion Dependent Thalassemia

Prospective Study of Complement Activation with Functional and Genetic Assays in Sickle Cell Disease

Sickle-Cell Disease in Greece: Patient Reported Outcomes Related to Clinical Complications, Treatment Choices and Attitudes, Beliefs and Trends Affecting Potential Participation in Clinical Trials - a Greek National Multicentric Study

Plasmic and Plasic Αre Εxcellent Predictors of Severe ADAMTS13 Deficiency in Thrombotic Microangiopathy Patients without Secondary Causes

Hepatitis C Virus Infection, but Not Hepatic Iron Overload Is the Dominant Risk Factor for the Manifestation of Hepatocellular Carcinoma Among Greek Thalassemic Patients

Neurological Manifestations Due to Extramedullary Hematopoiesis in Greek Patients with Thalassemia Intermedia: Not Such a Rare Clinical Finding

The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions

Demographic, Clinical and Laboratory Features, Management and Outcome of Immune Thrombocytopenia (ITP) in Greece: The National ITP Registry of the Hellenic Society of Hematology

Patients with Myelodysplastic Syndromes, Other Than Del(5)q Syndrome, Exhibiting Del(5)q Alone or Associated with One Additional Chromosomal Abnormality Have Comparable Probability and Duration of Response to Lenalidomide, with Patients Classified As Del(5)q Syndrome

Greek Registry of Myelofibrosis: Baseline Characteristics and Therapeutic Strategy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only